The Design of a GLP‐1/PYY Dual Acting Agonist
Author:
Affiliation:
1. Global Research Technologies Novo Nordisk Research Park 2760 Maaloev Denmark
2. Global Drug Discovery Novo Nordisk Research Park 2760 Maaloev Denmark
Publisher
Wiley
Subject
General Chemistry,Catalysis
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/anie.202016464
Reference81 articles.
1. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013
2. Health Effects of Overweight and Obesity in 195 Countries over 25 Years
3.
4. Fasting Plasma Glucose in the Screening for Type 2 Diabetes in Morbidly Obese Subjects
5. Diabetes trends in the U.S.: 1990-1998.
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Acute nicotine intake increases feeding behavior through decreasing glucagon signaling in dependent male and female rats;Hormones and Behavior;2024-03
2. Universal Prior Authorization Template for glucagon like peptide-1 based anti-obesity medications: An Obesity Medicine Association proposal;Obesity Pillars;2023-12
3. Evolution of peptide YY analogs for the management of type 2 diabetes and obesity;Bioorganic Chemistry;2023-11
4. Engineering a potent and long-acting GLP-1/Y2 receptor dual agonist as a multi-agonist therapy for diabetes and obesity;Peptides;2023-11
5. A peptide triple agonist of GLP-1, neuropeptide Y1, and neuropeptide Y2 receptors promotes glycemic control and weight loss;Scientific Reports;2023-06-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3